Large Cap

MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
Wall Street Jumps Back To Record Highs, Dow Hits 40,000 As Inflation Fears Recede, Meme Stock Frenzy Returns: This Week In The Market
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
Wall Street Jumps Back To Record Highs, Dow Hits 40,000 As Inflation Fears Recede, Meme Stock Frenzy Returns: This Week In The Market
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers

Large Cap Recent News

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.
China Goes All In As Beijing Vows To Buy Unsold Properties: Chinese Stocks Rally, Copper Hits All-Time Highs
China announces aggressive measures to boost property market, including easing mortgage rules and urging local governments to purchase unsold homes. Stocks and commodities tied to China rally in response to the news.
FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients
FDA approves Amgen's Imdelltra for treating ES-SCLC, based on response rate and DoR in clinical studies. Approval may depend on further trials.
Waste Management Mulls $3B Sale Of RNG Business: Report
Waste Management is seeking to sell its renewable natural gas business for about $3 billion. The company is working with JPMorgan to gauge interest from potential buyers.
Equinor Reportedly Scores Final Permit, Empire Wind 1 To Blast Off In 2026
Equinor received approval to build Empire Wind 1 offshore wind farm, expected to contribute to NY's goal of 9,000 MW of offshore wind power by 2035.
Major Indexes Close In The Red, Dow Falls Below 40,000 As Investors Make U-Turn On Economic Outlook
Dow Jones closes 0.1% lower; S&P 500 & Nasdaq 100 fall 0.2%; Mixed data on inflation, jobless claims and housing.
Dow Jones Hits 40,000, Chinese Tech Stocks Jump To 15-Month Highs, Bloodbath On Meme Stocks: What's Driving Markets Thursday?
U.S. major stock indices climbed higher on Thursday morning, with the Dow Jones Industrial Average achieving a historic milestone by surpassing 40,000 points.
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases.
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Roche's Genentech reported results from the Phase 1b trial of CT-388 for obesity and type 2 diabetes. The 24-week study showed significant weight loss and improved glycemic status in participants, with mild to moderate adverse events.
'Big Short' Investor Michael Burry Bets Heavy On Gold, Renewable Energy Stocks, Exits Amazon, Alphabet
Michael Burry, famous for predicting 2008 crisis, made headlines with his latest 13F filing. He shifted towards commodities & renewable energy and decreased holdings in tech giants.
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Ionis Pharmaceuticals and Biogen have halted development of BIIB105 for ALS after Phase 1/2 study results showed no impact on key clinical outcomes.
Boeing Stock Takes Off After US Aviation Bill Passes, But Possible Turbulence Ahead With Legal Uncertainties
Boeing faces regulatory changes, legal challenges, and mixed technical signals. While an aviation bill offers hope, DOJ's warning adds uncertainty.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers